Recently there has been an explosion in technological development in the life sciences, such that large quantities of biological data can be generated quickly. This has led to high interest and expectations regarding the possibilities for discovering new biomarkers. Our research group focuses on the development and use of statistical and other mathematical models to understand complex systems in infection biology.
Our main focus is to
- Identifying new biomarkers for early diagnosis of sepsis.
- Identifying biomarker profiles for immunosuppressive drugs.
- Developing tools to predict attacks by soil-borne plant pathogens.
- Studying the composition and function of cytosolic protein complexes activated during the course of inflammatory diseases and infections.
Our partners
- Skaraborg Hospital
- Örebro University
- University of Oxford
- Swedish University of Agricultural Sciences
- Unilabs AB
- Redoxis
- TATAA Biocenter AB
- HS Konsult AB
- bioMérieux Sweden AB
- MultiD Analyzes AB
- Frökontrollen Mellansverige AB
- QIAGEN AB
- Olink Proteomics AB
- 1928 Diagnostics
- Danish Technical University
- Copenhagen Business School
- Charles University
- Danube University
- German Institute for Standardization
- Nanoxis Consulting AB
Our areas of competence
- Infection biology
- Microbiology
- Immunology
- Systems biology
- Mathematical modelling
- Multivariate statistics